The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance. [PDF]
United European Gastroenterol J, 2023 Background: Clarithromycin resistance of Helicobacter pylori (H. pylori) represents a major challenge in eradication therapy. In this study, we assessed if non-invasive stool tests can be used to verify successful H.
Mommersteeg MC +10 more
europepmc +2 more sources
Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland [PDF]
Swiss Medical Weekly, 2023 BACKGROUND AND AIMS: Due to increasing antibiotic resistance, various Helicobacter pylori eradication regimens other than clarithromycin-based therapies have been proposed.
Tobias Braendli +5 more
doaj +2 more sources
Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates. [PDF]
BMC Res Notes, 2023 Background Treatment of Helicobacter pylori (H. pylori) infection has become challenging following the development of primary antibiotic resistance. A primary therapeutic regimen for H. pylori eradication includes clarithromycin; however, the presence of
Alavifard H +5 more
europepmc +2 more sources
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains. [PDF]
Turk J Gastroenterol, 2023 Background: The purpose of this study was to determine the antimicrobial status of stocked clinical Helicobacter pylori isolates by using antibiotic gradient test and subsequently identify the mutations that cause clarithromycin resistance by DNA sequencing.
Örsten S, Yılmaz E, Akyön Y.
europepmc +5 more sources
Prevalence and Variability of <i>Helicobacter pylori</i> Clarithromycin Resistance Mutations in Pediatric Patients in Poland: A Genotypic Analysis Using the Bosphore Genotyping Kit. [PDF]
Antibiotics (Basel)Background: Helicobacter pylori is a Gram-negative bacterium responsible for various gastrointestinal diseases, including peptic ulcers and gastric cancer.
Bogiel T +2 more
europepmc +2 more sources
Genetic basis of clarithromycin resistance in <i>Bacillus anthracis</i>. [PDF]
Microbiol SpectrABSTRACT The high-consequence pathogen Bacillus anthracis causes human anthrax and often results in lethal infections without the rapid administration of effective antimicrobial treatment.
Maxson T +9 more
europepmc +4 more sources
Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori. [PDF]
World J Gastroenterol, 2021 The drug resistance rate of clinical Helicobacter pylori (H. pylori) isolates has increased. However, the mechanism of drug resistance remains unclear. In this study, drug-resistant H. pylori strains were isolated from different areas and different populations of Chinese for genomic analysis.To investigate drug-resistant genes in H. pylori and find the
Li XH +9 more
europepmc +3 more sources
Mycobacterium avium strains resistant to clarithromycin and azithromycin [PDF]
Antimicrobial Agents and Chemotherapy, 1993 Mycobacterium avium strains susceptible to clarithromycin and azithromycin contain mutants resistant to these macrolides with a frequency of 1.1 x 10(-10) to 1.2 x 10(-6). Cross-resistance between clarithromycin and azithromycin was demonstrated with mutants selected in the laboratory as well as with resistant strains isolated from patients.
L, Heifets, N, Mor, J, Vanderkolk
openaire +2 more sources
Periodontology 2000, EarlyView., 2023 Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera +4 more
wiley +1 more source